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Wa-l mutant mice possess a defect in the production 
of transforming growth factor-a (TGF-a) that leads 
to a phenotype characterized by wavy hair and curly 
whiskers. In light of recent evidence indicating the 
importance of TGF-a in epithelial tumorigenesis, 
this study characterizes the responsiveness of wa-l 
mice to skin tumor promotion by the phorbol ester, 
12-0-tetradecanoylphorbol-13-acetate (TPA). The 
responsiveness of wa-1 mice to TPA was compared 
with that of SENCAR and C57BLl6 mice, represent-
ing mouse lines highly sensitive and resistant to skin 
tumor promotion, respectively. Wa-l mice were 
found to be very resistant to skin tumor promotion by 
TPA after initiation with 10 nmol DMBA, shnilar to 
C57BLl6 mice. TPA failed to induce a dramatic in-
crease in TGF-a mRNA and protein in the skin of 
T ransformin g growth factor- a (TGF-.a) is stru cturally homol ogous to epidermal growth factor (EGF) and can bind to and activate the epidermaJ growth factor receptor (EGFr) (Todal'O et ai, 1980; Massague, 1983; Derynck et ai, 1984; Wong et ai, 1989). T he EGF 
family now includes three other members that are also Hgands for 
the EGFr, including amphiregulin (Shoyab el ai, 1989), heparin-
binding EGF (HB-EGF) (Higashiyam3 et ai, 1991, 1995), and 
betacellulin (Shing el ai, 1993; Watanabe et ai , 1994) . Alth ough the 
effec ts of TGF-a are presumed to be m ediated through the EGFr, 
th e bio logic consequcnces are n ot n ecessari ly equivalent to those 
produced by EGF (Derynck , 1986; Derynck ct ai, 1987; Derynck, 
1988; M assague, 1990; Salomon el ai, 1990). Many human tumors, 
includin g squamous cell carcinomas of tbe skin, exhib.it eleva ted 
TGF-a mRNA or protein (or both) (Hendler and Ozanne, 1984; 
Merlino el ai , 1984, 1985; Ulllich el ai , 1984; Cowley el ai , 1986; 
Ozanne et ai, 1986; Yamamoto et ai, 1986; Derynck el ai, 1987; 
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wa-l mice, whereas TGF-a mRNA and protein were 
dramatically induced in the skin (both epidermis and 
dermis) of SENCAR and C57BLl6 mice. TPA treat-
ment dramatically increased mRNA levels of two 
other EGF receptor ligands, amphiregulin and hepa-
rin binding-EGF, however, in the skin of all three 
mouse lines. Comparison of histologic changes in 
skin revealed that wa-l mice exhibited only modest 
sustained epidermal hyperplasia after multiple treat-
ments with TP A, similar in magnitude to that o f 
C57BLl6 mice and significantly lower than that of 
SENCAR mice. The current data indicate that wa-l 
mice are relatively resistant to TPA promotion. Pos-
sible mechanisms for this resistance are discussed. 
Key lVords: EGFreceptol' ligalldlampllil'egulinllJepm'ill-billd-
i1lg EGF. ] Invest Del'llwtol 108:784-791, 1997 
Ishikawa ef nl, 1990; Reiss ef nl, 1991). R ecent findings £i'om several 
laboratories, including our own (Furstenberger et ai, 1989; 
Ima1110to ef nl , 1991; DiGiovanni, 1992; Kiguchi cf aI , 1995), have 
provided evidence tha t TGF-Q plays an important l'Ole during the 
promotion phase of multistage skin carcinogenesis. In this regard. 
we have shown that m echanistically diverse tumor-promoting 
stimuli elevate TGF-a mRNA and protein ill SEN CAR mouse 
epidermis, sugges ting that elevated levels of TGF-Q may play all 
essenti al role in mitogenic stimulation during tumor promotion 
(ImamotD el nl . 1991; Kiguchi el nl, 1995) . In addition, the 
papillomas ,lIld squamo us cell carcin omas that are produced by 
initiation-promotion regimens in m o use skin have significantly 
eleva ted TGF-Q mRNA and protein (Rho el nl, 1994) . These lat.ter 
data indicate that constitutive overexpression of TGF-C' occurs in 
very early papillomas and sugges t tha t tlus change is important for 
the development of autonomous growth in the papillomas pro-
duced in mouse skin. Furthermore, targeted overexpression of 
TGF-a co keratinocytes in mouse epidermis leads to a h yperplastic 
phenotype (Vassar and Fuchs, 199 1; Donune), ef ai, 1993 ). Inter-
estingly, wounding or chemical tumor promotion can lead to the 
production of papillomas in these TGF-a transgenic mice, suggest-
ing that overexpression of TGF- a may also substitute for the 
activation of H a-rns in this model system (Vassar and Fuchs, 1991: 
W ang c( nl, 1994). Finally, elevated TGF- a expression has been 
detected in papillomas generated by the transfection of norrual 
keratinocytes w ith v-Ha- rns fo ll owed by grafting of these ce lls int 
chambers on nude mi ce (Glick e( aI, 1993). All of these sttldie 
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strongly support an impo rtant role for TGF-a (or, more correctly, 
signaling throug h the EGFr) during the early stages of skin carci-
nogen esis in mice. 
Recently, the mouse mutation known as wa-1 was aSCL;bed to 
the TGF-a locu s (Luetteke e/ nl, 1993; Mann el nl, 1993). Wa-1 
mice exhibit a ch aracteristic phenorype of wavy h air and curly 
whiskers , w hich appears to result from a defect in the production of 
TGF- a mRNA and protein (Luetteke cl nl, 1993; Mann e/ nl, 1993) . 
That unde rproduction of TGF-a leads to the wa-1 phe notype was 
confirmed recently b y the development ofTGF-a null mice (Mann 
el aI, 1993) . T he TGF-a null mice exh.ibite d a phenotype almost 
identical to the wa-1 phenorype (Mann el nl, 1993). In addition, the 
wa- 1 mutar.ion was mappe d to the TGF-a locus on chromosome 6 
(Green, 1989; Fowl er e/ nl, 1993 ). Little e lse is currently knovvn 
regarding the nature of the wa-1 mutation , a lthough wa-1 mice do 
exhibit low levels ofTGF- a prote in expression (Mann e/ nl, 1993) 
and m.RNA express ion (Luettek e el nl, 1993). Nevertheless, the 
availability of mice deficient in the production of TGF-a provides 
a valuable tool for delinea ting tile role of this growth factor in skin 
carcinogenesis. 
T Ilis study was designed to compare the response of wa-1 mice 
with that of SENCAR and C57BL/6 mice using the tumor 
promoter, 12-0-tetradecanoylph orbol-1 3-acetate (TPA) . The 
SEN CAR and C57BL/6 mouse strains represent extremes in 
sensItivIty to the tumo r promoter TPA (DiGiovanni cl nl, 1980; 
Hennings cl nl, 1981; Ashman et nl , 1982; Reiners e/ nl, 1984; Lev.rjs 
and Adams, 1987; DiGiovalUli el nl. 1988, 1991). As part of tillS 
srudy, the three mouse lines w ere compared with regard to their 
responsiveness to TPA-induced hyperplasia, d e rmal inflammation 
response, and tumor promotion after 7,12-dimerhylbenz[n]anthra-
cene (DMBA) initiation. In addition , the induction of TGF-a , 
amphi.regulin , and HB-EGF mRNA and protein (TGF- a only) in 
response to TPA n'eatme nt was exanllned in a ll tllree mouse lines. 
The results indicate tllat wa-1 mice are less responsive to TPA for 
several of the histologic parameters analyze d and are quite resistant 
[0 skin tutTIor promotion by TPA. Although w a-1 were also 
res istant to the induction of TGF-a in skin by TPA treatment, 
amphiregu lin and HB-EGF mRNA levels were dramatically in-
duced in these mice. The results are discussed in terms of the role 
of genetic background in susceptibility to tumor promotion in wa- 1 
mice. 
MATEIUALS AND METHODS 
Chemicals and Biologic Agents TPA was obtained from LC Services 
(Woburn, MA) . Guanidinc iso thjocyanate was obtained frornGIBCO BRL 
(Ga ithersburg, MD). Lithium chloridc, 3,3' -diaminobenz ldmc, and bro-
modeo,,)'uridine were purchased fi'om Sigma Chemical Co. (St. Louis, 
MO). ['2PjdCTP (3000 Cilmmol) was obtained from NEN Research 
Products (Boston . MA). Polyclonal anti-TGF-a was obtained from R c-
search and Diagnostic Antibodies (Berkeley, CAl , and Au orescein isothio-
cyanate (F1TC)-conjuga ted goat anti-rabbit 19G (H + L) was obtained from 
Jackson Immuno Research Laboratories. Inc. (West Grovc. PAl· Tissue-
Tck OCT compound was obtained from Miles (Elkhart, IN). Rat TGF-a 
was obtained from Calbiochem (La J oll a. CAl · 
Anitnals and Trcatluents Wa- l 111ice (breeders) were o btained fro III 
tne Jackson Labo rator)' (Ba r Harbor, ME). \Va- I homozygous mutant mice 
were brother-sister mated in our animal resource fac ility. SEN CAR and 
C57BL/6 mice were obtained from the National Cancer Institute (Freder-
ick, MD) and the Jackson Laboratory, respectively. All mice were used at 
7- 9 wk of age. at which time the backs of the mice were ca refull y shaved 
with surgical clippers . O nl y those mice in the resting phase of the hair 
growth cycle we re subscquentl y used. Gro llps of thrce to four SENCAR. 
wa-l, a nd C57BL/6 mice were sacrificed at variolls times after multiple 
treatments with TPA. Mul tiple tr"atments were performcd acco rding ro 
reginlen s that yield 111;txilllal responses for skill tunlo r prOll1o rio n (K.ruszc\v-
,ki el nl, 1987. 1989). The mice received a total of four applications ofTPA 
(0.85- 6 .8 nnlOl in 0.2 1111 "cetone) givcn twice a week. Control .mice 
received sitnilOlr trc atJn cnts with acetone . For itlltnUllo histochcrnjca l analy-
ses, whole skin sectio ns were covered with OCT cOlllpo und and frozen at 
-70°C befo re sectioning. fixation . and furthc r processing. 
TlUIlor Induction Experimcnts Grollps of 10- 20 mice cach wcre 
initiated with DM13A (10 nmol per mOll se) lInless otherwise specified. Two 
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\veeks afte r ini tiation . rnice received top ica l app li c.·u:io ns of variolls doses of 
TPA in 0.2 1111 acetone for 16 wk. The incidence of skin papillomas was 
observed and rccorded wcekly. Control mjce rcceived only tI,C acetone 
vehicle at the time of initiation. fo llowed by applications of TPA as 
indic;lted. Tumor data are expressed as the percentage of mice with 
papillomas (tumor incidencc) and thc average number of papillomas pe r 
mouse (tumor multiplicity). 
Northern Blot Analysis After treatment. the mice were killed by 
ce rvical dislocation ; the dorsal skins were treated with a depilatory agent 
(Na ir; Cm·tc r Products, Cannbury, NJ) for 30 s and thcn removed and 
snap-fi'ozen in liquid nitrogen. Total R NA was iso lated using the acid 
guanidine iso thiocyanate method (Chomczynski and Sacchi, 1987). Twenty 
micrograms of roml RNA was electrophorescd through 1%, agarose-6% 
formaldehydc ge ls and transferred to GencScrccn nylon membranes (NEN 
R.esearch Products). For the detection of TGF-a and amphiregnlin tran-
scripts, cD NA fragments of397 and 303 bascs. respccrively, were generated 
lIsing reverse rrallscdptasc and I"<lllciolt1 hcxanlt: rs (Life Technologies. 
Gaithersburg, MD), followed by polymcrase chain reaction ampljfi cation 
(GcneAmp PCR. kit; Perkin-Elmer. Branchburg, NJ). T he probc used for 
HB-EGF was a rat cDNA kindly providcd by Dr. Shigeki Higashi ya llla 
(Osaka University Medica.l SchooL Japan). Filte rs wcre a.lso hybridized with 
a probe for 7s ribosomal n .NA (PA6) to verify equiva.lent loading and 
rransfer of R.NA (Balmain er nl, 1982). The PA6 probe was a gift fi'om Dr. 
Tim Dowden (Unive rsity of Arizona. T ucson. AZ). Probes were radiola-
beled using a randomly primcd DNA Iabcling ki t (Promcga Corp., Madison, 
WI) and [a _32 PjdCTP. Labe led probes were purified on NICK columns 
(Pharmacia LKn. Uppsala . Sweden) before use. 
Indirect Immunofluorescence Staining for TGF-a Skin sections 
excised at variou s tinlCS after prOll1otcr trcatntent w ere covcred \vith OCT. 
snap-fi·ozen. and storcd at -70°C . Approximately 5-[..I.lll frozen sec tions 
were Cllt with a cryostat. Afte r fixation with ~% para for maldehyde. the 
scctions werc treared with a polyclonal TGF-a antibody and FITC-
conjugated anti-rabbit goa t IgG. Furthcr dcrai ls arc as described previously 
(Kiguchi or nl. 1995). 
Quantification of Epidermal Labeling Index (LI) Mice were given 
an intrapcritone<ll injection of '1 00 [..I.g bromodeoxyuridine (BrdU) per gram 
body weight. The mice wcre killed and the dorsal skin was removed 30 min 
aftcr injection. The skins werc fixed with 10% phosphate-buffe red formalin 
for 24 h. embedded in panlffin. and cut in to -I-/.un thjck sec tions. After 
deparaffin ization with ,-),Iene, the sections were rinsed in 0.01 M phosphate-
buffered saline. hydrolyzed with I N HCI at 42 °C for 20 min. and 
digestcd with 0.05% protease at room te mperature for 20 min. T he sec tions 
were then incubated with anti-BrdU (Bccton-Dickinson, San J osc, CAl 
di lu ted 1 :25 in phosphate-buffered salinc with 0.5% Tween. followed by 
incubation with biotinylatcd anti-mollse IgG. The avidin-biotin peroxidase 
complex method was used for detection (Vectast<lin; Vector Laboratories. 
Inc., Burlingamc, CAl . The epidermal U was then determined by counting 
thc BrdU-stained basal cell s, as described previously (Naito cr 01. 1988). 
Measurement of Epidermal Thickness and Quantification of Poly-
morphonuclear Leukocyte (PMN) Infiltration Skin sections were 
fIxed in 10% formalin. embeddcd in paJ'affi n. and sta ined with hematoxylin 
and eosin. The measuremcnt of epidermal th.i ckness (except the horny 
la)'er) and the quantification ofPMNs pCI' 125 X 125 [..I.m vertica l section of 
dermis were pcrformed using an O lympus ocular micrometer (Tokyo. 
Japan) at objectivc lens magnification o f eithcr 40 X or I OO X . At leas t 12 
;l reas of a scction fi'om each block wcrc measured at random fo r each 
paranlctcr. 
RESULTS 
Wa-l and C57BL/6 Mice Were Less Responsive to TPA-
Induced Hyperplasia Figure lA d epicts the time course of the 
epidermal hyperplasia response, m easure d as chan ges in e pidermal 
thickness , in wa-1, C57DL/ 6, and SEN CAR mlce afte r four 
treatments with 3.4 nmol T PA. In creases in e pidermal thi ckness 
occurred in all three m o use lines. with a maximum level at 
approximately 48 h. As expected, a sig nifi cantly lower le vel of 
h yperplasia was o b serve d in C57BL/6 mice. Notably. the h yper-
plasia response of the wa-1 nllce was also signifi cantly lower than 
that of the SEN CAR. mice and o nl y slightly high er tha n that of the 
C57BL/ 6 mice at every time point. Figure lB shows the epidermal 
thickness va lues for the three m ouse lines 48 h afte r the las t of fo ur 
treatments over a dose range of 0.85-6.8 I1mo l TPA p er m o u se. 
The increase in epiderma l thick.ness was concentration-dependent 
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Figure 1- Wa-l and C57BLl6 mice were 
significantly less responsive to TPA-in- 100 
duced hyperplasia. Tim e-colIrse (A) and A 
dose-response (B) experiments of epidermal E 80 
hyperp lasia ill \va-1 , CS7BLl6 (C57), and .3 
(3.4 III SENCAR 1l11Ce after multiple TPA III OJ 
nnlOl) treatments. G ro ups of three mi ce each c 60 -'" u 
received fOlIr appli cations of TPA given E l-
tw ice a wec k for 2 wk. Mice were killed at Cii 40 E various times after the las( treatment . Epider-
'" mal thickness was m easured from the bilse- "0 '0. 
111ent ll1 elllbrrm c the top of the granular w 20 to 
layer. Contro l anl1nals 'were trcated with 
acetone and sacrifi ced at the same time as the 0 
TPA-treaced ll1ice. Data repr.esent mean ± Acetone 6h 12h 
SD in three to four mice per g roup . 
in all three lines, although the TPA-induced increases in epidermal 
thickness w ere greatest in SEN CAR mice and were significantly 
higher than in wa-l and C57BL/6 l11ice at all doses examined. As 
in Fig lA, wa-1 mice were similar to C57BL/6 mice in respon-
siveness to TPA over the dose range examined . 
The Increase in Epidermal LI in Wa-l Mice After TPA 
Treatment Was Lcss Than That in SEN CAR But Greater 
Than That in C57BLl6 Mice Figure 2A shows the changes in 
epidermal LI as a fun ction of time after the la st of four treatments 
with 3.4 nl1101 TPA in SENCAR, wa-1 , and C57BL/ 6 mice. The 
epidermal Ll increased to a maximum between 24 and 48 h in 
SEN CAR mice and was signifi cantly greater than in either wa-1 o r 
C57B L/6 mice. For the first 24 h after TPA treatment. the 
m agnitude of the epide rmal LI in wa-1 and C57BL/6 mice was 
simij;lr; however, at 48 hand 72 h , the epidermal Ll in wa-1 mice 
was significan tly grea ter than in C57BL/6 mice. This pattern of a 
1110re persistent elevation in LI in w a-1 mi ce than in C5 7BL/ 6 mice 
was observed at all of rhe doses examined except at the lo west dose 
of 0.85 nmol. Figure 2B shows the changes induced in epidermal 
LI 48 h after the last TPA tr'eatment o ver a dose range of 0.85-6.8 
nnw I. Interestingly, the LI increased in both SEN C AR and wa-1 
mi ce such that at the 3.4- and 6.8-nI1101 doses, the epidermal LI in 
wa-1 mice was signifI cantly greater than in C57BL/6 mice. The 
epidermal LI in wa-1 mice was significantly lower than that of 
SEN CAR mice at all doses ofTPA (p < 0.01 at all doses) . Figut'e 
3 shows representative skin sections from SEN C AR, wa-1, and 
C57BL/6 mice stained with anti-BrdU antibody showing the 
labeled celJs. 
The Degree ofTPA-Induced PMN Initiation in Wa-l Mice 
Was Significantly Higbet' Than That in C57BLl6 and Was 
Similar to That in SENCAR Mice T PA induced a signifIcant 
dermal infiltration of PMNs in SENCAR and wa-1 mice, with the 
111aximum levels occurring at 12 and 18 h , respectively, after the 
24h 
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last of four trea tments of 6.8 I1mol TPA (SENCAR, 13-13.2 per 
125 X 125 f.Lm of dermis; wa-l, 11.6-1 2.5 per 125 X 125 f.L111 of 
dermis). T he res ults of this experim ent are shown ill Fig 4. 
Notably, th e degree of PMN infiltration was vel')' similar in 
SENCAR and wa-1 mice. In contrast, little or no infiltration of 
dermal PMNs was observed in CS7BL/6 mice at an)' of the time 
examined over a 4-d period . The results with SENCA}l alld 
C57BL/6 mice are very simila r to those obta in ed previo usly by 
other laboratories, as well as our own (Lewis and Adams, 1987; 
Naico et (I I , 1987). 
Wa-l and C57BLf6 Mice Wcre Extrcmcly Rcsistant to 
TPA-Induccd Skin Tumor Promotion The results of an 
experiment comparing rbe skin tIll110r promo tion sensitivity of 
wa-1 mice wit.h that of SEN CAR and C57BL/6 mice are summa-
rized in Table 1. For these experiments. gro ups of mi ce were 
ini tia ted with 10 I1mo l DMBA and then 2 wk later received 
twice-weekly treatments with various doses ofTPA . As shown in 
Table I , wa-l mice were ex tremely resistant to skin tumor 
promotion by TPA tinder the conditions of this experiment. in 
contnlst, "fter J 8 wk of promotion, 100'1., of SENCAR mice bore 
papill omas. As expected , no tumors were observed in C 57BL/6 
mice througbout the experiment (DiGiovanni cf nl , 1988, '[991). 
TPA Treatment Failed to Induce TGF-a mRNA Levels in 
Wa-l Mice and Led to Elevation of Amphiregulill and 
HB-EGF in Wa-l, C57BLl6, and SENCAR Mice Northem 
blot analys is demonstrated that four app lication s of 3.4 nmol TPA 
transiently elevated the level o f a 4.8-kb TGF-a transcript in total 
RNA £l'om the skin o f SEN CAR and C57BLl6 mice (Fig 5). Levels 
of the TGF-ll' transcript were alread)' elevated above th e control 
level at 6 h (the earlies t time point examined) in botb SENCAR and 
C57BL/6 mice and remained elevated for at least 72 h in both of 
these strains. Furthermore, no differences in the ma gnitude of this 
response were observed between these mouse jines. In contrast. 
Figure 2. The increase in epidermal LI 
in wa-l mice after TPA treat.ment was 
less than that in SENCAR but greater 
than that in C57BL/6 mice. T ime-course 
(A) and dose-response (B) experiments of 
epiderm~1 Ll in wa-1 . C57BLl6 (C57), and 
SEN CAR mice after Illultiple T PA (3 .4 
nmol) treatments. Groups of three mice each 
received four applicarions of T PA given 
[Wice a week for 2 wk. Mice were ki ll ed 
48 h after the h, sr rreatment. Control animals 
were trea ted 'with aceto ne and sacrifi ced at 
the sam e time as the TPA-trea red Illice . 
Mice "eceivcd 1 00 (.Lg of BrdU intraperi ro-
nealJ y 30 min before , ,, crifi ce. Each va lue fo r 
rh e percentage of 13rdU-st<lincd cell s (i.e. , 
labeling in.dex) was calculated fi'olll the ob-
servarion of sao basa l ce lls. Da t" re presenr 
m ean ± SD ill three to four mice per grollp. 
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Figure 3. The relative responsiveness of Ll after TPA treatment was SENCAR > wa-l > C57BLl6 . BrdU sta ining of the skin of wa-l ('''1'). 
C57BL/6 (",iddlc), and SENCA R (bottrl/ II ) mice 411 h afccr the last offom treatm ents with acetone (A,C ,E) or TPA (6.8 n l11ol) (B,D, rj. Control anima ls were 
trea ted with acetone and kill ed at the same ti ll1 e as the TPA-o'cated mice . Senff bnr, 30 j.t111. 
TPA failed to indu ce elevated levels of TGF-O' mRNA in w<l-1 
mice . T he expression ofTGF-a mRN A in the skin of contro l wa-1 
mice was also significantly lower than the level of expression in 
either SENCAR or C57BL/6 control mice. as expected based on 
published data (Luetteke el nl, 1993; Mann ('( nl. 1993) . In contrast, 
TPA significan tly indu ced mRNAs for both amphiregulin and 
HB-EGF in the skin of SENCAR, wa-l, and C57Bl/6 mice (see 
again Fig 5) . Note that in the experiment shown in Fig 5, the 
magnitude of the T PA-indu ced amphiregulin mRNA was similar 
(2- to 3-fold) at all time points comparin g wa-\ and SEN CAR 
mice, w hereas the m agni tude of thi s in crease was higher (4- to 
9-fold) in C57B L/6 mice. Similar resu lts were obtained 111 repeat 
experiments. 
Wa-l Mice Had Significantly Lower Levels of TGF- a Pro-
tein To determine whether the lack of induction of TGF-a 
mRNA was accompanied by a lack of production ofTGF- a protein 
in w3-1 mice, we performed immunoflu orescence analyses on 
fi'oze n skin sections taken fro m mi ce 24 h after the last of fou r 
appli cations of 6.8 nmol T PA. An IgG fraction of anti-rat TGF-a: 
antiserum was Ll sed to localize m ouse TGF- O' in these sections. T he 
results of th ese experiments are shown in Fig 6 . In the control skin 
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Figure 4_ The degree of TPA-induced PMN infiltration in wa-l 
mice was s ignificantly higher than that in C57BLl6 and was similar 
to that in SENCAR mice_ Dermal infiltra tion of PMNs in wll-l, 
C 5713U6 (C57), and SENCA R mice. T he PMN v'llu e is thc m ean of 12 
different 125 X '1 25 f1.H1 vertica l sectio ns with a maximum variatiol1 of13%. 
Gro ups of three mice each received four applications of6.8 11111 0 1 TPA twice 
a week for 2 wk. Mice were killed <It vari ous times aftcr tbe lase treatment. 
(a ceto ne- treated) of SENCAR mice (Fig 6B) , the epidermis and 
hair follicles showed ligh t smiJling for TG F-Q protein . The same 
control section, stain ed only with secondary FITC-conjugated 
antibody, exhibited a typical light o range background staining in 
Waved-1 
TGFu 
HB-EGF HB-EGF 
AR AR 
PA6 PA6 
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Table I. Wa-l and C57BLl6 Mice Are Extremely 
Resistant to TPA-Induced Skin Tumor Promotion After 
DMBA Initiation" 
TPA Mice With 
Mouse D ose No. of Papillomas Tumor Incidence 
Strain Initiator (nmol) Mice ('Vo ) (Papillomas/ Mouse) 
SENCAR Acetone 1.7 20 15 0. 15 
DMBA '1.7 20 100 9.4 
w a-l Acetone 6 .8 to 0 0 
DMBA 1.7 18 0 0 
DMBA 3.4 18 0 0 
DMBA 6.8 19 0 0 
C57I3U6 Acetone 6.8 20 0 0 
DMBA 1.7 20 0 0 
DMBA 3.4 20 0 0 
DMBA 6.8 20 0 0 
(/ E:u:h group or mice was illiri:tccd witl ! e ither 10 1Jnlo l of DMllA or acetone 
(control) foll o wed 2 w k filter by twice- weekI), appJic:![ion.Ii o f TPA for 16 wk. 
the stratum corneu m and hair shafts (Fig 6A) . The specificity of 
staining for TGF-Q in mouse epidermis was verified by the addition 
of exogenous rat TGF-Q to the primary antibody, which caused a 
substantial reducdon of specific staining in the control skin of 
SENCA1<' mice (data no t shown). 
In contrast, hyperplastic epidermis of SEN CAR mice induced by 
TPA showed intense and widespread staining for TGF-Q protein ill 
all epidermal layers as well as in the hair follicles (Fig 6C) . 
Scattered areas of intense TGF-a staining were also observed in the 
dennis of SENCAR mice. T his sc,ltcercd staining in the dermis was 
more prevalent in the TPA-treated skin of SEN CAR mice than in 
control SENCAR mice (compare Fig 6B and 6C) . The wa-l mice 
had significantly lower levels ofTGF-a pro tein in both control (Fig 
6D) and TPA-created sectiollS (Fig 6E). In addition, the scattered 
staining pattern observed in the dermis of SENCAR mice was nor 
as intense .in the dermis of wa-1 mice. 
C57BLl6 SENCAR 
.r: 
N 
HB-EGF 
AR 
PA6 
'2 
c 
o 
o 
Figute 5. TPA failed to induc" c\c,"at"d levels ofTGF-a mRNA in wa-1 mice, and TPA tteatment led to elevation ofampbircguUn ana 
HD-EGF in ",,,-1, CS7BL/6, and SENCAR Ll~ic". R.clative TGF-a, :lml'hiregulin (A l~), and HB-EGF tnnscript levels detected by Northern blot anal)'sis 
in wa-I , C57 I3 L/6, and SENCAR Ino use skin after fOLlr app lications of3.4 lunol ofTPA . Mice were ki ll ed at various times after the last treatment . T Otal 
R NA was e lectrophoresed in " I "/,. agarosc- 6% fOl'lll;l ldehydc gel. The bl ot was hybridized with radiolabcled probes for TGF-a, H13-EGF, and amph.iregulin. 
T he blots were r"probed with ;\ eDNA for PA6 to COll trol for RNA IO'lding. Relati ve transcript leve ls arc expressed as a percentage of the acetone control 
and ha ve been l1 0nnalized aga inst the tra\\s<:ril' t for PA6. NIIIII&er,. indicate the time (in h) after the las t treatment. 
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DISCUSSION 
This study has explored the ability of TPA to induce epidermal 
hyperplasia and skin tumor promotion in wa- lmice. The study was 
designed to compare the responses of wa-1 mice with those of 
SENCAR and C57BL/6 mice to TPA treatment. The major 
findings of this study are as fo llows. (i) Wa-l mice w ere signifi-
can tly less responsive to TPA-induced hyperplasia as measured by 
epidermal thickness (the re lative responsiveness was SEN CAR » 
wa-1 - C57BL/6). (ii) T he in crease in epiderma l LI in wa- 1 mice 
after TPA treatment was less than that in SEN CAR but greater than 
tha t in C57BL/6 (the relative responsiveness was SEN CAR > 
wa- 1 > C57BL/6) . (iii) The degree ofTPA-induced PMN inftltra-
tion in wa- 1 mi ce was significantly higher than that in C57BL/6 
and was similar to that in SEN CAR mice (the relative responsive-
ness was SENCAR - wa-1 > CS7BL/6) . (iv) TPA treatment led to 
eleva ted levels ofTGF-a: trallScripts in total RNA samples isolated 
from the skin of SEN CAR and C 57BL/6 mi ce. No difrerence in the 
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Figure 6 . Wa-l mice had significantly lower levels of TGF- ll' 
protein in both control and TPA-treated sections, and TPA-treatcd 
epidermis of SENCAR mice showed more intense staining for 
TGF- ll' protein than control. Localization of TGF-a protein by immu-
nofluorescence in wa- l and SENCAR mouse skin 48 h after the last of fom 
treatments with TpA (3.4 m11 ol) given twice a wee k for 2 wk. (A) 
SEN CAR , secondary FITC -conjugated antibody only; (B) SEN CAR, ace-
tone- treated group; (C) SEN CAR, TPA-treated group ; (D) W3-1. acetone-
treated gro up ; (E) wa-J , TPA-treated group. Senlc I",,., 30 fJ.111. 
ma gnitude of this response was observed between these mouse 
lin es . In contrast, at the doses ll sed in the present study, TPA fai led 
to induce elevated levels of TGF-CY mRNA in wa-1 mi ce. In 
addition , hyperplastic epidermis of SEN CAR mice indu ced by TPA 
showed more intense and widespread staining for TGF-CY pro tein 
than control SENCAR mice by immunohi stochemical analysis . 
\X' a-1 mice had signit-1 cant1 y lower leve ls of TGF- a: protein in bo th 
control and TPA-treated sections. (v) TPA treatment led to the 
elevation of other EGFr liga nds including amphiregulin and HB-
EGF. (vi) Wa - l mice were extremely resistant to TPA-induced skin 
tumor promotion after DMBA ini tiation. The relative responsive-
ness to TPA skin tumor promotion was SENCAR. » wa- 1 -
CS7BL/6 . Overall. th e data indicate that the resistan ce of wa-\ 
mice to TPA promotion is not due to the lack of production of 
TGF-CY after TPA treatment. but rather to the presence o f genetic 
factors conferring relati ve resistance of this mouse line to TPA 
promotion. 
790 I( IGUC HI ET AL 
Recen tly, it was reported that introdu ction of v-Ha-rns into 
primary cu.1tures o f mouse keratin ocytes, usin g a retroviral vec to r, 
stimul ated the growth of wa-l keratinocytes and elicited ch ara c-
te ri stic changes in m arker expression associated w ith EG Fr acti va-
tion (D lu gosz ('I aI , 1995). In addi tion, v-Ha- rns ke ratin ocytes £i'om 
wa-l mice produced squamolls tum ors w hen graFted o nto /lude 
mi ce, similar to v-Ha-ms-infected kcratinocytes from contro l 
(TGF- £l' + I + ) and TGF-£l' null mi ce (Dlugosz et al. 1995). 1n bo th 
the v-Ha-rns keratin ocytes and the resul ting tum ors, tran scripts 
encoding additi onal EGP famil y members includin g <l lllphiregulin , 
HB-EGF-like growth facto r. and betace llulin w ere strikln gly in-
du ced, whereas TGF-a transcripts were n o t. It was suggested based 
on these resul ts th at TGf- a is not essential for epidermal n eoplasm s 
indu ced by the v-Ha-ras oncogene and that oth er EG Fr ligands m ay 
contribute to th e au tocrin e growth stimulation of these v-Ha-rns-
transformed keratinocytes . O ur current res ults show th;lt wa-l 
mi ce, per sr, arc extrem ely resistant to T P A-induced skln tum or 
prom oti on under th e conditions of this tumor exp eriment. Further-
m ore, N orthern blo t analysis dem on stra ted tha t T PA treatment 
fu iled to induce elevated levels of TG F-C/ transcripts in w a-l mice. 
T PA treatment of wa-l mice led to a dramatic induction o f 
amphireglllin and HB-EG F mRNA, however. T herefore, it is also 
unlike ly tbat the m echanism for resistance to T PA promo tion in 
wa-I mice is due to a lack of signaling thro ugh the EGFr, as these 
altern ati ve EGFr ligands were abundantly expressed in TPA-treated 
epide rmis. 
Altho ugh the exact m echanism s fo r th e resistance of wa-l mice 
to skin tumor promotion are no t known at present, a strong 
possibility lies in their gene tic makeup. In this regard , wa-ll'nice are 
on a gene tic background , ABP/ le, fo r which little is known 
regarding susceptibility to skln tumorigenesis, induding skin tumor 
promotion. In the present study, several histologic changes in the 
skin of wa- l mice w ere compared with those in SEN C AR mice, 
w l'lich arc highly sensit ive to skin tumor promo tion by TPA, and in 
C57BL/6 mice, w hich are highly resistant to tumor promotion by 
TPA (DiGiovanni c( aI, 1980; H ennin gs el aI , 198 1; Ashman e( aI, 
1982; R einers el aI , t 984; DiGiovanni , t 989). Previous studies 
(reviewed in DiGiovanni, t 995) have shown that sustained epider-
mal hyperpla sia correlates with tumor-prol1lo ting efficacy among 
tumor-promo tin g chemicals and that mice sen sitive to tumor 
promotion by T PA dispJa y a po tentiated epidermal hyperplasia after 
lllul tipl e tl·ell tments . In addition, tumor promo ter-induced denl1al 
infl ammati on is a compon ent of th e skin response in sensitive 
mouse stocks and strain s, al though the necessity for severe inflam-
mation is no t cl ear at present (Kle in-Szanto , 1984). T he results of 
our study sho wed that TPAillduced signifi cantl y less epidermal 
hyperpl asia and a lower LJ in wa-1 mice than in SEN C AR. 
Epidermal hyperplasia induced by TPA in wa-I mice was compa-
ra ble to th at induced in C57BL/6 mice . In addition , although T PA 
induced an e leva ted epidermal L1 in \." a-1 mice tha t was signifi-
cantl y greilter than in C5 7B LI 6 mi ce at som e tim e points and doses, 
it was signifi can tly low er than. in SEN C AR mice at all doses and all 
tim e points (except 6 h) (Fig 2A,B) . T hus , the epidermal pro lifer-
ative response to T PA in wa-l mice was more like that ofC57BL/6, 
a tumor prom otion-resistant mouse strain , than of th e highly 
sensiti ve SEN CAR mice. 
An interes ting o bservation in the current study arose fi om 
comparison o f a component of th e inflammatory response in the 
three lines o f mice. In thi s rega ~'d , it is well esta bli shed that 
C57BL/6 mi ce show li ttle or no derm al infl ammatory r esponse 
afte r T PA treatm ent , whereas SEN CAR mice show a dramati c 
inflamma tol'Y response (Lewis and Adams, 1987). A dram ati c 
infil tr ati on of derm al PMNs is characteristi c o f this response in the 
SENCAR mOllse, whereas few, if any, PMN s can be de tected in 
C57BL/6 skln after TPA treatm ent. T he data in Fig 4 show a 
dram atic infil tration of PMNs in wa-l mice with a time course 
identica l to that o f T PA . T hus, in terms of this aspect of the 
inflamma tol'y response. W 3-J mi ce were more lik e SEN CAR than 
C 57BL/ 6 mi ce. T hese daca suggest a possible di ssociation between 
th e dermal in fIltration of PMNs and susceptibility to T PA promo-
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cion. It is interesting to n ote tbat several o ther studies reported in 
the literature (Fisher et nl, 1987; N aito et nl , 1987 , 1988) ha\'~ 
reached a similar conclusion . T hus, wa-l mi ce may be a useful 
m odel to study furth er v"rious components o f the dermal inflam-
ma tory response in relation to epidermal hyperpl as ia and tumor 
promotion . 
In conclusion, th e current study has shown that wa-1 mice are 
vcr)' resistant to skin tumor promotion by the phorbo l ester TPA. 
Wherea s TGF-CI levels are extremely low in the epidermis of wa-l 
mi ce and are not induced by TPA, o ther EG Fr ligands (i.e., 
amphiregt.1lin and H B-EGf) are dramatica lly e levated . These data. 
support th e conclusion that lack of TGF-C/, per se, does no t coufe r 
r esist,l11ce to TPA promotion . It is ass umed tha t other EGFr ligand 
can substi t ute for T G F- £l' during tumor promotion by TPA. O n the 
o ther hand , the data suggest that wa-1 mice are genetically resistant 
to skln tU.m or promo tion by a mechanisrn as ye t unknown. T Q 
explore these possibili ties fur ther , the wa-1 muta tion is being bred 
onto the SEN C AR backgro und for additional studies. 
I,V" 1I';.<h to Ihnllk Melissn BrnrllClJor II er ('xfe/klll secrelnrial skiffs ill II, e prcj!nl'Oti"" 
0I lhi" 'II nlll/scrip/. HIe ntso rllnl/I, Ms .)"d), l"gJi'r p rc!'llI'mio" '~f}JI"'log ,.n)Jl,s. Tllis 
resenrch //Ins s lIpporl ed 1) / Ullil ('d Stnt es P"Mic H en llil SerlJ ice C rmlts CA.]71!! nltd 
CA575 96, (l il t! Core .~rnll is CIl 16672 nlld £S0 7784- 01 . 
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